PAIM
ELOS

Punch & Associates Investment Management’s Syneron Medical Ltd ELOS Stock Holding History

Punch & Associates Investment Management’s Portfolio ELOS Stock Details ELOS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-483,211
Closed -$3.46M – 279
2015
Q3 		$3.46M Buy
483,211
+3,961
+0.8% +$38.1K 0.47% 89
2015
Q2 		$5.09M Sell
479,250
-49,337
-9% -$578K 0.64% 61
2015
Q1 		$6.54M Buy
528,587
+46,285
+10% +$512K 0.81% 41
2014
Q4 		$4.5M Sell
482,302
-19,361
-4% -$187K 0.58% 70
2014
Q3 		$5.03M Sell
501,663
-63,627
-11% -$647K 0.7% 53
2014
Q2 		$5.83M Sell
565,290
-27,067
-5% -$293K 0.78% 39
2014
Q1 		$7.38M Sell
592,357
-33,210
-5% -$393K 1.01% 24
2013
Q4 		$7.69M Buy
625,567
+52,459
+9% +$545K 1.04% 24
2013
Q3 		$4.94M Buy
573,108
+4,390
+0.8% +$37.9K 0.77% 37
2013
Q2 		$4.95M Buy
+568,718
New +$5.09M 0.87% 28

Other funds holding ELOS

SM
Senvest Management New York $3.01B AUM 35.7% 1-Year Est. Return
NTC
North Tide Capital Boston, Massachusetts $469M AUM 6.57% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
DGHMC
Dalton, Greiner, Hartman, Maher & Co New York $126M AUM 92.88% 1-Year Est. Return
BIP
Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
SAM
Senzar Asset Management New York $34.7M AUM 0.56% 1-Year Est. Return
IAM
Ion Asset Management Herzliya, Israel $911M AUM 24.97% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Punch & Associates Investment Management's ELOS Position: Q4 2015 in Review

Punch & Associates Investment Management sold out of Syneron Medical Ltd (ELOS) in Q4 2015, closing a stake of 483,211 shares — an estimated $3.46M sold.

Punch & Associates Investment Management first reported a position in ELOS in Q2 2013 and held it in 10 quarters. The position peaked at $7.69M in Q4 2013. 57 funds tracked by Wall St. Rank hold ELOS as of Q4 2015.

  • Punch & Associates Investment Management reported no remaining Syneron Medical Ltd position as of Q4 2015 after selling out during the quarter.
  • Punch & Associates Investment Management sold 483,211 Syneron Medical Ltd shares in Q4 2015, an estimated $3.46M.
  • Punch & Associates Investment Management first reported a position in Syneron Medical Ltd in Q2 2013 and held it in 10 quarters.
  • Punch & Associates Investment Management's Syneron Medical Ltd position peaked at $7.69M in Q4 2013.
  • 57 funds tracked by Wall St. Rank held Syneron Medical Ltd as of Q4 2015.

Based on Punch & Associates Investment Management's 13F filing for Q4 2015, filed 28 Jan 2016.